Kleo

Kleo is developing two small molecules to treat cancer, infectious diseases, and a broad range of indications: Antibody Recruiting Molecules (ARMs) and Synthetic Antibody Mimics (SyAMs). They believe that their technology represents a breakthrough in safer, more effective, and more convenient treatment options.